Spatial mapping of the biologic effectiveness of scanned particle beams: Towards biologically optimized particle therapy

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Guan, Fada ^a   Bronk, Lawrence ^b   Titt, Uwe ^a   Lin, Steven H ^a,b   Mirkovic, Dragan ^a   Kerr, Matthew D ^a   Zhu, X Ronald ^a   Dinh, Jeffrey ^b   Sobieski, Mary ^c   Stephan, Clifford ^c   Peeler, Christopher R ^a   Taleei, Reza ^a   Mohan, Radhe ^a   Grosshans, David R ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURVIVAL; ELEMENTARY PARTICLE; HUMAN; MONTE CARLO METHOD; RADIATION RESPONSE; RADIOTHERAPY; RELATIVE BIOLOGIC EFFECTIVENESS; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELEMENTARY PARTICLES; HUMANS; MONTE CARLO METHOD; RADIOTHERAPY; RELATIVE BIOLOGICAL EFFECTIVENESS;

EID: 84929646152     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09850     Document Type: Article

References (60)

1. Schulz-Ertner, D. & Tsujii, H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 25, 953-964, doi:10.1200/JCO.2006.09.7816 (2007).
2. Allen, A. M. et al. An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. Radiother Oncol 103, 8-11, doi:10.1016/j.radonc.2012.02.001 (2012).
3. Wedenberg, M. & Toma-Dasu, I. Disregarding RBE variation in treatment plan comparison may lead to bias in favor of proton plans. Med Phys 41, 091706, doi:10.1118/1.4892930 (2014).
4. Halperin, E. C. Particle therapy and treatment of cancer. Lancet Oncol 7, 676-685, doi:10.1016/s1470-2045 (06) 70795-1 (2006).
5. Combs, S. E. et al. Comparison of carbon ion radiotherapy to photon radiation alone or in combination with temozolomide in patients with high-grade gliomas: explorative hypothesis-generating retrospective analysis. Radiother Oncol 108, 132-135, doi:10.1016/j.radonc.2013.06.026 (2013).
6. Schardt, D., Elsaesser, T. & Schulz-Ertner, D. Heavy-ion tumor therapy: Physical and radiobiological benefits. Reviews of Modern Physics 82 doi:10.1103/RevModPhys.82.383 (2010).
7. Burigo, L., Pshenichnov, I., Mishustin, I. & Bleicher, M. Comparative study of RBE and cell survival fractions for 1H, 4He, 12C and 16O beams using Geant4 and Microdosimetric Kinetic model. arXiv preprint arXiv;1403.7929 (2014).
8. Paganetti, H. et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 53, 407-421. (2002).
9. Paganetti, H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol 59, R419-472, doi:10.1088/0031-9155/59/22/R419 (2014).
10. Britten, R. A. et al. Variations in the RBE for Cell Killing Along the Depth-Dose Profile of a Modulated Proton Therapy Beam. Radiat Res 13, 13 (2012).
11. Calugaru, V. et al. Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay. Int J Radiat Oncol Biol Phys 81, 1136-1143, doi:10.1016/j.ijrobp. 2010.09.003 (2011).
12. Chaudhary, P. et al. Relative Biological Effectiveness Variation Along Monoenergetic and Modulated Bragg Peaks of a 62-MeV Therapeutic Proton Beam: A Preclinical Assessment. Int J Radiat Oncol Biol Phys, doi:10.1016/j.ijrobp. 2014.05.010 (2014).
13. Britten, R. A. et al. Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam. Radiat Res 179, 21-28, doi:10.1667/RR2737.1 (2013).
14. Lin, S. H. et al. A high content clonogenic survival drug screen identifies mek inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancer. J Thorac Oncol 9, 965-973, doi:10.1097/JTO.0000000000000199 (2014).
15. Lee, S. J., Lee, H. J. & Moon, D. H. Quantitative analysis of thymidine kinase 1 and 5' (3')-deoxyribonucleotidase mRNA expression: the role of fluorothymidine uptake. Anticancer Res 31, 2135-2139 (2011).
16. Carmichael, J., De Graff, W. G., Gazdar, A. F., Minna, J. D. & Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47, 936-942 (1987).
17. Lai, S. L., Perng, R. P. & Hwang, J. p53 gene status modulates the chemosensitivity of non-small cell lung cancer cells. J Biomed Sci 7, 64-70, doi:25431 (2000).
18. Puck, T. T. & Marcus, P. I. Action of x-rays on mammalian cells. J Exp Med 103, 653-666 (1956).
19. Franken, N. A., Rodermond, H. M., Stap, J., Haveman, J. & van Bree, C. Clonogenic assay of cells in vitro. Nat Protoc 1, 2315-2319, doi:10.1038/nprot.2006.339 (2006).
20. Chamberlain, A. C. & Turner, F. M. Errors and Variations in White-Cell Counts. Biometrics 8, 55-65, doi:10.2307/3001526 (1952).
21. Wilén, E. A simplified method of phytoplankton counting. British Phycological Journal 11, 265-278, doi:10.1080/00071617600650551 (1976).
22. Gerweck, L. E., Dullea, R., Zaidi, S. T., Budach, W. & Hartford, A. Influence of experimental factors on intrinsic radiosensitivity assays at low doses of radiation: cell multiplicity. Radiat Res 138, 361-366 (1994).
23. Voger, E. A. & Bussian, R. W. Short-term cell-attachment rates: a surface-sensitive test of cell-substrate compatibility. J Biomed Mater Res 21, 1197-1211, doi:10.1002/jbm.820211004 (1987).
24. Twentyman, P. R. Timing of assays: an important consideration in the determination of clonogenic cell survival both in vitro and in vivo. Int J Radiat Oncol Biol Phys 5, 1213-1220 (1979).
25. Wu, R. C. & Schonthal, A. H. Activation of p53-p21waf1 pathway in response to disruption of cell-matrix interactions. J Biol Chem 272, 29091-29098 (1997).
26. Lewis, J. M., Truong, T. N. & Schwartz, M. A. Integrins regulate the apoptotic response to DNA damage through modulation of p53. Proc Natl Acad Sci U S A 99, 3627-3632, doi:10.1073/pnas.062698499 (2002).
27. Kang, M. A., So, E. Y. & Ouchi, T. Deregulation of DNA damage responsepathway by intercellular contact. J Biol Chem 287, 16246-16255, doi:10.1074/jbc. M111.337212 (2012).
28. Kapiszewska, M., Reddy, N. M. & Lange, C. S. Trypsin-induced changes in cell shape and chromatin structure result in radiosensitization of monolayer Chinese hamster V79 cells. Int J Radiat Biol 60, 635-646 (1991).
29. Huang, H. L. et al. Trypsin-induced proteome alteration during cell subculture in mammalian cells. J Biomed Sci 17, 36, doi:10.1186/1423-0127-17-36 (2010).
30. Ogata, T. et al. Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res 65, 113-120 (2005).
31. Akino, Y. et al. Carbon-ion beam irradiation effectively suppresses migration and invasion of human non-small-cell lung cancer cells. Int J Radiat Oncol Biol Phys 75, 475-481, doi:10.1016/j.ijrobp. 2008.12.090 (2009).
32. Suetens, A. et al. Dose- and time-dependent gene expression alterations in prostate and colon cancer cells after in vitro exposure to carbon ion and X-irradiation. J Radiat Res, doi:10.1093/jrr/rru070 (2014).
33. van Bree, C. et al. G0 cell cycle arrest alone is insufficient for enabling the repair of ionizing radiation-induced potentially lethal damage. Radiat Res 170, 184-191, doi:10.1667/RR0845.1 (2008).
34. Barendsen, G. W., Van Bree, C. & Franken, N. A. Importance of cell proliferative state and potentially lethal damage repair on radiation effectiveness: implications for combined tumor treatments (review). Int J Oncol 19, 247-256 (2001).
35. Little, J. B. Factors influencing the repair of potentially lethal radiation damage in growth-inhibited human cells. Radiat Res 56, 320-333 (1973).
36. Baskar, R. Emerging role of radiation induced bystander effects: Cell communications and carcinogenesis. Genome Integr 1, 13, doi:10.1186/2041-9414-1-13 (2010).
37. Belli, M. et al. Inactivation of human normal and tumour cells irradiated with low energy protons. Int J Radiat Biol 76, 831-839 (2000).
38. Belli, M. et al. RBE-LET relationships for cell inactivation and mutation induced by low energy protons in V79 cells: further results at the LNL facility. Int J Radiat Biol 74, 501-509 (1998).
39. ICRU Report 86, Quantification and Reporting of Low-Dose and other Heterogeneous Exposures. Journal of the ICRU 11, 51-60 (2011).
40. Petrovic, I. et al. Response of a radioresistant human melanoma cell line along the proton spread-out Bragg peak. Int J Radiat Biol 86, 742-751, doi:10.3109/09553002.2010.481322 (2010).
41. Freedman, V. H. & Shin, S. I. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3, 355-359 (1974).
42. Fiebig, H. H., Maier, A. & Burger, A. M. Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery. Eur J Cancer 40, 802-820, doi:10.1016/j.ejca.2004.01.009 (2004).
43. Scholz, C. C., Berger, D. P., Winterhalter, B. R., Henss, H. & Fiebig, H. H. Correlation of drug response in patients and in the clonogenic assay with solid human tumour xenografts. Eur J Cancer 26, 901-905 (1990).
44. Fertil, B. & Malaise, E. P. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 11, 1699-1707 (1985).
45. Michalowski, A. A critical appraisal of clonogenic survival assays in the evaluation of radiation damage to normal tissues. Radiother Oncol 1, 241-246 (1984).
46. Hall, E. J. & Giaccia, A. J. Radiobiology for the radiologist. 6th edn, (Lippincott Williams & Wilkins, 2006).
47. Wilkens, J. J. & Oelfke, U. Optimization of radiobiological effects in intensity modulated proton therapy. Med Phys 32, 455-465 (2005).
48. Tibbitt, M. W. & Anseth, K. S. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 103, 655-663, doi:10.1002/bit.22361 (2009).
49. Griffith, L. G. & Swartz, M. A. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 7, 211-224, doi:10.1038/nrm1858 (2006).
50. Howes, A. L., Richardson, R. D., Finlay, D. & Vuori, K. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems. PLoS One 9, e108283, doi:10.1371/journal.pone.0108283 (2014).
51. Chambers, K. F., Mosaad, E. M., Russell, P. J., Clements, J. A. & Doran, M. R. 3D cultures of prostate cancer cells cultured in a novel high-throughput culture platform are more resistant to chemotherapeutics compared to cells cultured in monolayer. PLoS One 9, e111029, doi:10.1371/journal.pone.0111029 (2014).
52. Mizoe, J. E. et al. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 69, 390-396, doi:10.1016/j.ijrobp. 2007.03.003 (2007).
53. Agostinelli, S. et al. Geant4-a simulation toolkit. Nuclear Instruments and Methods in Physics Research Section A 506, 250-303 (2003).
54. Allison, J. et al. Geant4 developments and applications. IEEE TRANSACTIONS ON NUCLEAR SCIENCE 53, 270-278 (2006).
55. Zhu, X. R. et al. Commissioning dose computation models for spot scanning proton beams in water for a commercially available treatment planning system. Med Phys 40, 041723, doi:10.1118/1.4798229 (2013).
56. Paganetti, H. Four-dimensional Monte Carlo simulation of time-dependent geometries. Phys Med Biol 49, N75-81 (2004).
57. Smith, A. et al. The M. D. Anderson proton therapy system. Med Phys 36, 4068-4083 (2009).
58. Gillin, M. T. et al. Commissioning of the discrete spot scanning proton beam delivery system at the University of Texas M. D. Anderson Cancer Center, Proton Therapy Center, Houston. Med Phys 37, 154-163 (2010).
59. Haynes, W. M. CRC Handbook of Chemistry and Physics, 95th Edition. (CRC Press, 2014).
60. Berger, M. J., Coursey, J. S., Zucker, M. A. & Chang, J. ESTAR, PSTAR, and ASTAR: Computer Programs for Calculating Stopping-Power and Range Tables for Electrons, Protons, and Helium Ions (version 1.2.3). [Online] Available: http://physics.nist.gov/Star [2014, July 23] National Institute of Standards and Technology, Gaithersburg, MD. (2005).